[Duration of adjuvant treatment with tamoxifen in patients with resectable breast cancer]

[Duration of adjuvant treatment with tamoxifen in patients with resectable breast cancer]

Tamoxifen administered in patients after breast cancer surgery is one of the most effective adjuvant treatments in this pathology. A large number of randomized studies including thousands of patients allowed to quantify the treatment benefits in terms of recurrence, contralateral breast cancer and o...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Davies, C, Arriagada, R, Ziegler, A, Peralta, O
Μορφή:	Journal article
Γλώσσα:	Spanish; Castilian
Έκδοση:	1998

Παρόμοια τεκμήρια

[Adjuvant tamoxifen duration: more large-scale randomized evidence is needed]
ανά: Davies, C, κ.ά.
Έκδοση: (1997)

Variation in use of adjuvant tamoxifen.
ανά: Davies, C, κ.ά.
Έκδοση: (1998)

Adjuvant treatment with tamoxifen. Recruitment into studies assessing optimum duration of treatment must continue.
ανά: Earl, H, κ.ά.
Έκδοση: (1996)

Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival.
ανά: Gelber, R, κ.ά.
Έκδοση: (1996)

Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen
ανά: Dowsett, M, κ.ά.
Έκδοση: (2009)

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer
ανά: Early Breast Cancer Trialists' Collaborative Group
Έκδοση: (1988)

Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer
ανά: Jaime D. Lewis, κ.ά.
Έκδοση: (2014-11-01)

Extended adjuvant tamoxifen for early breast cancer: a meta-analysis.
ανά: Mustafa Al-Mubarak, κ.ά.
Έκδοση: (2014-01-01)

Tamoxifen therapy for patients with breast cancer - Authors' reply.
ανά: Davies, C, κ.ά.
Έκδοση: (2013)

Tamoxifen for Breast Cancer
ανά: A Karn, κ.ά.
Έκδοση: (2010-03-01)

Switching to exemestane after 2-3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen.
ανά: Davies, C
Έκδοση: (2004)

Early breast cancer: How long should tamoxifen continue?
ανά: Davies, C, κ.ά.
Έκδοση: (1999)

Which adjuvant endocrine therapy for ER-positive non-metastatic breast cancer? EBCTCG-2000 update: Tamoxifen, castration, LHRH-agonists
ανά: Davies, C, κ.ά.
Έκδοση: (2002)

Early breast cancer: How long should tamoxifen continue?
ανά: Davies, C, κ.ά.
Έκδοση: (1998)

Tamoxifen for early breast cancer: better late than never.
ανά: Gray, R, κ.ά.
Έκδοση: (2000)

Dosage-dependent reduction of macular pigment optical density in female breast cancer patients receiving tamoxifen adjuvant therapy
ανά: Lim, I-Liang, κ.ά.
Έκδοση: (2018)

Features of ovarian steroidogenesis and endometrial hypertrophy during adjuvant therapy with tamoxifen in premenopausal patients with hormone-dependent breast cancer
ανά: A. Yu. Goryainova, κ.ά.
Έκδοση: (2023-05-01)

10 vs 5 years of adjuvant tamoxifen: exclusion of 1/402 centres in ATLAS
ανά: Davies, C, κ.ά.
Έκδοση: (2017)

WITHDRAWN: Tamoxifen for early breast cancer.
ανά: Clarke, M
Έκδοση: (2008)

Analysis of information received during treatment and adherence to tamoxifen in breast cancer patients
ανά: Aline Cruz, κ.ά.
Έκδοση: (2017-12-01)

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
ανά: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Έκδοση: (2011)

Tamoxifen in breast conservation therapy.
ανά: Lee, K, κ.ά.
Έκδοση: (1995)

Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
ανά: L. V. Bolotina, κ.ά.
Έκδοση: (2014-07-01)

The gut microbiota during tamoxifen therapy in patients with breast cancer
ανά: Lars E. Hillege, κ.ά.
Έκδοση: (2025-03-01)

Leuprolide Acetate Treatment for Ovarian Cysts in Breast Cancer Patients Under Tamoxifen Therapy
ανά: Şafak Yılmaz Baran, κ.ά.
Έκδοση: (2022-12-01)

Adjuvant treatment for breast cancer
ανά: Flatley, M, κ.ά.
Έκδοση: (2019)

EFFECTS OF ADJUVANT TAMOXIFEN AND OF CYTOTOXIC THERAPY ON MORTALITY IN EARLY BREAST-CANCER - AN OVERVIEW OF 61 RANDOMIZED TRIALS AMONG 28,896 WOMEN
ανά: Peto, R
Έκδοση: (1989)

Breast cancer hormone receptor levels and benefit from adjuvant tamoxifen in a randomized trial with long-term follow-up
ανά: Helena Fohlin, κ.ά.
Έκδοση: (2024-07-01)

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
ανά: Davies, C, κ.ά.
Έκδοση: (2013)

Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
ανά: Mele, T, κ.ά.
Έκδοση: (2010)

Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
ανά: Mele, T, κ.ά.
Έκδοση: (2010)

Pharmacogenetics of tamoxifen in breast cancer patients of African descent: Lack of data
ανά: Bianca Kruger, κ.ά.
Έκδοση: (2024-03-01)

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
ανά: Davies, C, κ.ά.
Έκδοση: (2013)

Tamoxifen for early breast cancer: an overview of the randomised trials
ανά: Early Breast Cancer Trialists' Collaborative Group
Έκδοση: (1998)

Modern breast cancer therapy: from tamoxifen to T-cell engineering
ανά: Yu. A. Shevchenko, κ.ά.
Έκδοση: (2022-11-01)

Sox2 promotes tamoxifen resistance in breast cancer cells
ανά: Marco Piva, κ.ά.
Έκδοση: (2013-10-01)

Laparoscopic bilateral salpingo-oophorectomy for recurrent ovarian endometriotic cysts in a woman taking adjuvant tamoxifen for breast cancer: A case report
ανά: Hajime Takeuchi, κ.ά.
Έκδοση: (2024-10-01)

The Role of Adjuvant Radiotherapy in the Treatment of Breast Cancer
ανά: Iveta Kolářová, κ.ά.
Έκδοση: (2024-02-01)

Auraptene Boosts the Efficacy of the Tamoxifen Metabolites Endoxifen and 4-OH-Tamoxifen in a Chemoresistant ER+ Breast Cancer Model
ανά: Angel Pulido-Capiz, κ.ά.
Έκδοση: (2024-09-01)

Ultrasonic, hysteroscopic and histological evaluation of the endometrium in women receiving tamoxifen for breast cancer
ανά: N. S. Melnikova, κ.ά.
Έκδοση: (2014-07-01)